Summit VetPharm Offers New Flea Topical Vectra for Dogs & Puppies(TM) For Long-Lasting Protection
Dinotefuran and Pyriproxyfen Combination Delivers Safe and Effective Control of All Stages of Fleas on Dogs
Vectra for Dogs & Puppies(TM):
- Kills adult fleas; starts killing fleas within 2 hours
- Provides ongoing protection against fleas and the diseases they may transmit, including tularemia, bartonellosis and rickettsiosis
- Protects dogs from flea infestations that may cause anemia, tapeworm disease and flea allergy dermatitis (FAD)
- Contains an IGR — pyriproxyfen — stable in sunlight, prevents development of all immature flea stages (eggs, larvae and pupae) for 1 month
- Can be used on puppies as young as 8 weeks of age
- Patented applicator provides convenient topical treatment
Vectra for Dogs & Puppies(TM) efficacy data confirms that it has one of the quickest onsets of killing activity of any topical flea product, while providing month-long protection against all stages of fleas (eggs, larvae, pupae and adult fleas). “In a study conducted to evaluate the duration of adulticide activity against fleas for Vectra(R) in dogs weighing 21-55 pounds, Vectra(R) began killing fleas within 2 hours following a single application and continued to perform for 30 days maintaining a 100% reduction in fleas throughout the duration of the study,” explained Dr.
“Pet owners want fleas killed as quickly as possible to end their dog’s suffering,” says Dr. Ball. “Oftentimes, the successive feeding activity of fleas on dogs elicits a hypersensitivity skin disorder known as flea allergy dermatitis (FAD). Treatment of dogs with Vectra for Dogs & Puppies(TM) kills fleas and may reduce further evidence of FAD.”
Pet owners and their dogs have a variety of lifestyles. Differing lifestyles, coupled with the differing parasites endemic to the area of the country, means their vector protection needs may be different. “Vectra for Dogs & Puppies(TM) is the perfect companion to Vectra 3D(R),” says
Vectra for Dogs & Puppies(TM) dual-action formula includes dinotefuran, a fast-acting, third generation neonicotinoid with a novel mode of action and pyriproxyfen, an insect growth regulator (IGR) that controls and prevents the development at all immature flea stages including eggs, larvae, and pupae. Tested with up to five times the recommended dose, Vectra(R) showed no significant adverse effects.
The unique, elongated, patented applicator tip makes Vectra for Dogs & Puppies(TM) easy to apply to a dog’s skin through the hair coat. The rounded tip minimizes risk of skin abrasions. The easy-to-open applicator eliminates splash back and spilling, and the contoured shape makes it easier to handle and apply. With the one-piece applicator, there is no need to use scissors to open or remove a cap, making application fast and efficient, and at the same time, minimizing the potential of a choking hazard.
Summit VetPharm’s Bloodhound(R) Technology — an innovative, proprietary track and trace system, ensures veterinary exclusivity and authenticity of the product. Each package of Vectra(R) can be traced from the point of manufacture to the veterinary purchase. Bloodhound(R) Technology allows Summit VetPharm to maintain the integrity of its products through a secure distribution channel, as well as, guarding against counterfeits. “We are able to enhance the role of veterinarians in the lives of the animals they treat. Through our Bloodhound(R) Technology, we can help keep companion animal health in the hands of professionals,” states Stephanus.
Vectra for Dogs & Puppies(TM), Vectra(R) for Cats & Kittens, Vectra for Cats(R) and Vectra 3D(R) are available to veterinarians through Summit VetPharm and Abbott Animal Health sales representatives, as well as from the following distributors: Henry Schein Animal Health, Midwest Veterinary Supply, Inc., Merritt Veterinary Supplies, Inc., NLS Animal Health, PCI Animal Health, Sanum Puerto Rico, Victor Medical Company and Webster Veterinary.
Founded by veterinarians and experienced industry professionals, Summit VetPharm is committed to protecting the health and welfare of both companion animals and companion animal veterinary practices. Based in
SOURCE Summit VetPharm